Zobrazeno 1 - 10
of 204
pro vyhledávání: '"D. Soysal"'
Autor:
Marie-Anne Meier, Sandro Nuciforo, Mairene Coto-Llerena, John Gallon, Matthias S. Matter, Caner Ercan, Jürg Vosbeck, Luigi M. Terracciano, Savas D. Soysal, Daniel Boll, Otto Kollmar, Raphaël Delaloye, Salvatore Piscuoglio, Markus H. Heim
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-8 (2022)
Meier, Nuciforo, Coto-Llerena et al. report a rare case of a patient with hepatocellular carcinoma with neuroendocrine differentiation. The authors establish organoids that recapitulate the genetic features of the patient’s tumor and are used for e
Externí odkaz:
https://doaj.org/article/092df1cdee254031870f4d0caaa0bd75
Autor:
John Gallon, Mairene Coto‐Llerena, Caner Ercan, Gaia Bianco, Viola Paradiso, Sandro Nuciforo, Stephanie Taha‐Melitz, Marie‐Anne Meier, Tujana Boldanova, Sofía Pérez‐del‐Pulgar, Sergio Rodríguez‐Tajes, Markus vonFlüe, Savas D. Soysal, Otto Kollmar, Josep M. Llovet, Augusto Villanueva, Luigi M. Terracciano, Markus H. Heim, Charlotte K. Y. Ng, Salvatore Piscuoglio
Publikováno v:
Molecular Oncology, Vol 16, Iss 3, Pp 665-682 (2022)
Hepatocellular carcinomas (HCCs) usually arise from chronic liver disease (CLD). Precancerous cells in chronically inflamed environments may be ‘epigenetically primed’, sensitising them to oncogenic transformation. We investigated whether epigene
Externí odkaz:
https://doaj.org/article/01ede92b5b01440d89da11c31958e65e
Autor:
Caner Ercan, Mairene Coto-Llerena, John Gallon, Lana Fourie, Mattia Marinucci, Gabriel F. Hess, Jürg Vosbeck, Stephanie Taha-Mehlitz, Tuyana Boldanova, Marie-Anne Meier, Alexandar Tzankov, Matthias S. Matter, Martin H. K. Hoffmann, Luca Di Tommaso, Markus von Flüe, Charlotte K. Y. Ng, Markus H. Heim, Savas D. Soysal, Luigi M. Terracciano, Otto Kollmar, Salvatore Piscuoglio
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-8 (2022)
Plain language summary Focal nodular hyperplasia (FNH) is a lesion resulting from the abnormal growth of liver cells. It is typically considered a benign tumor that does not become malignant. In rare cases, FNH may occur alongside malignant hepatocel
Externí odkaz:
https://doaj.org/article/49161dc05fb841fc951e15d1ae5a8794
Autor:
Mairene Coto‐Llerena, Nadia Tosti, Stephanie Taha‐Mehlitz, Venkatesh Kancherla, Viola Paradiso, John Gallon, Gaia Bianco, Andrea Garofoli, Souvik Ghosh, Fengyuan Tang, Caner Ercan, Gerhard M. Christofori, Matthias S. Matter, Raoul A. Droeser, Mihaela Zavolan, Savas D. Soysal, Markus vonFlüe, Otto Kollmar, Luigi M. Terracciano, Charlotte K. Y. Ng, Salvatore Piscuoglio
Publikováno v:
Hepatology Communications, Vol 5, Iss 4, Pp 661-674 (2021)
Transcriptional enhancer factor domain family member 4 (TEAD4) is a downstream effector of the conserved Hippo signaling pathway, regulating the expression of genes involved in cell proliferation and differentiation. It is up‐regulated in several c
Externí odkaz:
https://doaj.org/article/ad421c0d13494136915e7f00b44e48ef
Autor:
Sofia Zanotti, Gina F. Boot, Mairene Coto-Llerena, John Gallon, Gabriel F. Hess, Savas D. Soysal, Otto Kollmar, Charlotte K. Y. Ng, Salvatore Piscuoglio
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Hepatocellular carcinoma (HCC) typically develops from a background of cirrhosis resulting from chronic inflammation. This inflammation is frequently associated with chronic liver diseases (CLD). The advent of next generation sequencing has enabled e
Externí odkaz:
https://doaj.org/article/8a66c79ba6ce4402b89db4555700e707
Autor:
Mattia Marinucci, Caner Ercan, Stephanie Taha-Mehlitz, Lana Fourie, Federica Panebianco, Gaia Bianco, John Gallon, Sebastian Staubli, Savas D. Soysal, Andreas Zettl, Stephan Rauthe, Jürg Vosbeck, Raoul A. Droeser, Martin Bolli, Ralph Peterli, Markus von Flüe, Charlotte K. Y. Ng, Otto Kollmar, Mairene Coto-Llerena, Salvatore Piscuoglio
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
The use of patient-derived organoids (PDO) as a valuable alternative to in vivo models significantly increased over the last years in cancer research. The ability of PDOs to genetically resemble tumor heterogeneity makes them a powerful tool for pers
Externí odkaz:
https://doaj.org/article/46f54f28e2a04b6b8aeeecf5a0b65447
Autor:
Robert Mechera, Savas D. Soysal, Salvatore Piscuoglio, Charlotte K. Y. Ng, Jasmin Zeindler, Edin Mujagic, Silvio Däster, Philippe Glauser, Henry Hoffmann, Ergin Kilic, Raoul A. Droeser, Walter P. Weber, Simone Muenst
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background The Rearranged during Transfection (RET) protein is overexpressed in a subset of Estrogen Receptor (ER) positive breast cancer, with both signalling pathways functionally interacting. This cross-talk plays a pivotal role in the re
Externí odkaz:
https://doaj.org/article/5c49c750c1db409b9ceec48f5cd590dd
Autor:
Mairene Coto-Llerena, Caner Ercan, Venkatesh Kancherla, Stephanie Taha-Mehlitz, Serenella Eppenberger-Castori, Savas D. Soysal, Charlotte K. Y. Ng, Martin Bolli, Markus von Flüe, Guillaume P. Nicolas, Luigi M. Terracciano, Melpomeni Fani, Salvatore Piscuoglio
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Fibroblast activation protein α (FAP) plays an important role in tissue remodeling and helps tumor cells invade surrounding tissue. We sought to investigate FAP as a prognostic molecular marker in colorectal cancer (CRC) using immunohistochemical an
Externí odkaz:
https://doaj.org/article/6f5808a753d44eb9a73ade37bf98aac5
Autor:
Silvio Däster, Serenella Eppenberger-Castori, Valentina Mele, Hannah M. Schäfer, Lukas Schmid, Benjamin Weixler, Savas D. Soysal, Raoul A. Droeser, Giulio C. Spagnoli, Christoph Kettelhack, Daniel Oertli, Luigi Terracciano, Luigi Tornillo, Urs von Holzen
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Prognosis of gastric and esophageal cancer is poor and treatment improvements are needed. Programmed cell death 1 receptor (PD-1) interaction with its ligand PD-L1 in tumor micro-environment promotes immune tolerance and blocking monoclonal antibodie
Externí odkaz:
https://doaj.org/article/4751443826274a429cf6b643bb3a11d0
Autor:
Mathilde Ritter, Ida Oberhauser, Giacomo Montagna, Lea Zehnpfennig, Kristin Schaefer, Barbara M. Ling, Jeremy Levy, Savas D. Soysal, Madleina Müller, Liliana Castrezana López, Fabienne D. Schwab, Christian Kurzeder, Martin Haug, Elisabeth A. Kappos, Walter P. Weber
Publikováno v:
Journal of Plastic, Reconstructive & Aesthetic Surgery. 75:3068-3077
This study aims to compare patient-reported outcomes (PROs) after different types of oncoplastic surgery (OPS) procedures and correlate the results with previously published normative data from women with no prior history of breast cancer (BC) and br